Stock listing

Diamyd Medical Ab Class B

Selected listing: DMN · GETTEX · EUR · DE

Diamyd Medical Ab Class B (gettex:DMN), Health Technology. Latest release Mar 23, 2026: Diamyd Medical enters into equity financing agreements with new U.S.…

DMN:GETTEXEURDEUpdated October 3, 2026

Ticker: gettex:DMN
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: gettex
Currency: EUR

About Diamyd Medical Ab Class B

Diamyd Medical Ab Class B (DMYD B) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.

Latest news from Diamyd Medical Ab Class B

Diamyd Medical enters into equity financing agreements with new U.S. sector specialist investors for up to USD 125 million and announces full enrollment in Phase 3 trial

March 23, 2026

Diamyd Medical announces finalization of database for interim analysis in Phase 3 DIAGNODE-3 trial

February 24, 2026

Diamyd Medical receives Notice of Allowance for key retogatein US patent

February 9, 2026

Diamyd Medical accelerates primary efficacy readout by 9 months in type 1 diabetes Phase 3 trial following FDA alignment and guidance

December 29, 2025

All Diamyd Medical Ab Class B news →

Events

Replays

Diamyd Medical AB (publ) (DMYD_B) Q2 2026 Earnings Call
Wed, Mar 25, 2026 · 04:00 AM ET
Watch
Diamyd Medical AB (publ) (DMYD_B) Q4 2025 Earnings Call
Wed, Oct 08, 2025 · 02:30 AM ET
Watch
Diamyd Medical AB (publ) (DMYD_B) Q3 2025 Earnings Call
Fri, Jul 25, 2025 · 02:00 AM ET
Watch

Research Diamyd Medical Ab Class B

Diamyd Medical Ab Class B company profile

View the public company page for Diamyd Medical Ab Class B on 6ix.

Diamyd Medical Ab Class B news

Read company news and market updates connected to Diamyd Medical Ab Class B.

Diamyd Medical Ab Class B investor events

Find investor webinars, events, and replay context for Diamyd Medical Ab Class B.